End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43 SEK | -0.92% | +1.90% | +28.74% |
Apr. 22 | EQL Pharma AB Announces Mellozzan Launched in Germany and Austria | CI |
Feb. 13 | EQL Pharma AB Provides Sales Guidance for the Year 2023/24 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.74% | 115M | |
-31.97% | 10.1B | |
+8.14% | 6.12B | |
-11.41% | 5.97B | |
-30.42% | 5.65B | |
-0.88% | 4.71B | |
+51.58% | 4.26B | |
-12.22% | 3.58B | |
-14.86% | 3.26B | |
-6.93% | 3.07B |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- EQL Pharma : Receives Regulatory Approval for Nausea, Vomiting Treatment in Sweden